戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1  tumor types (islet cell tumors and mucinous cystadenocarcinoma).
2 : glioblastoma multiforme and ovarian serous cystadenocarcinoma.
3 y cystadenomas, including one with a biliary cystadenocarcinoma.
4 MTC/PTC at low frequency (8%) and pancreatic cystadenocarcinoma.
5 ive cystic mucinous neoplasms, and only 7 as cystadenocarcinomas.
6 ine tumor (14%), pancreatic pseudocyst (6%), cystadenocarcinoma (3%), and miscellaneous (13%).
7 intraductal papillary mucinous neoplasm = 7, cystadenocarcinomas = 3) lesions.
8  compared our results to TCGA ovarian serous cystadenocarcinoma and uterine corpus endometrial carcin
9                                              Cystadenocarcinomas are thought to be less aggressively
10 WT/Trp53(R172H) mice also presented mucinous cystadenocarcinomas at 12 weeks of age, recapitulating h
11 ative mucinous cystic neoplasms, or invasive cystadenocarcinomas based on specific histologic criteri
12        Biliary cystadenoma (BCA) and biliary cystadenocarcinoma (BCAC) are rare tumors that arise in
13  diagnosis of biliary cystadenoma or biliary cystadenocarcinoma by 2 GI pathologists.
14  5 of the 6 patients surviving resection for cystadenocarcinomas died of recurrent cystadenocarcinoma
15 Herein, we described a case of hepatobiliary cystadenocarcinoma in female with chronic hepatitis B an
16                                Hepatobiliary cystadenocarcinoma is a rare epithelial malignant neopla
17             Early diagnosis of hepatobiliary cystadenocarcinoma is difficult because of its asymptoma
18 31; 5%), periampullary adenoma (n = 21; 3%), cystadenocarcinoma (n = 14; 2%), cystadenoma (n = 25; 4%
19 hree additional TCGA cohorts: ovarian serous cystadenocarcinoma (OVCA), sarcoma (SARC), and cutaneous
20 contrast, a histologic diagnosis of invasive cystadenocarcinoma portends a dismal prognosis, similar
21      The only two male patients with biliary cystadenocarcinoma received radical hepatic resection an
22  the molecular pathogenesis of hepatobiliary cystadenocarcinoma remains unclear.
23  neoplasm, cystic neuroendocrine tumors, and cystadenocarcinomas were considered to be premalignant o
24 y cystadenomas and two patients with biliary cystadenocarcinomas were retrospectively reviewed.
25 on for cystadenocarcinomas died of recurrent cystadenocarcinoma within 5 years.
26 eft lobectomy specimens showed hepatobiliary cystadenocarcinoma without accompanied mesenchymal strom
27                       Notably, hepatobiliary cystadenocarcinoma without mesenchymal stroma seldom occ